NDAQ:SNGX - Post Discussion
Soligenix Inc
> Soligenix Extends Patent Protection for its Filovirus Vaccin
Post by
whytestocks on Apr 25, 2024 12:45pm
Soligenix Extends Patent Protection for its Filovirus Vaccin
JUST IN: $SNGX Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South AfricaSoligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa PR Newswire Includes thermostabilized Ebola vaccines MarVax™ and SuVax™ Includes nanoemulsion adjuvant compatible with lyophilization ...
SNGX - Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa
Be the first to comment on this post